FDA.reportPublic FDA data

SECUADO 3.8 MG/Day 24HR Transdermal System

RxCUI
2265729
RxNorm name
SECUADO 3.8 MG/Day 24HR Transdermal System
Display name
SECUADO 3.8 MG/Day 24HR Transdermal System
Full name
SECUADO 3.8 MG/Day 24HR Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SECUADOASENAPINENoven Therapeutics, LLC685eaf44-5944-4f38-afba-0a4fc0b3462b2025-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2265729

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
685eaf44-5944-4f38-afba-0a4fc0b3462bSECUADO 3.8 MG/Day 24HR Transdermal System [PSN] · 24 HR asenapine 0.158 MG/HR Transdermal System [Secuado] [SBD] · 24 HR Secuado 0.158 MG/HR Transdermal System [SY] · Secuado 3.8 MG/Day 24 HR Transdermal System [SY]413These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 200920250130